Geopolitics Alpha

8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Eloxx Pharmaceuticals filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
  • Exposed: ELOX
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - Eloxx Pharmaceuticals, Inc.(0001035354) (Filer)ELOXGEOPOLITICS ALPHA

8-K - Eloxx Pharmaceuticals filed an 8-K with the SEC on Nov 16 (a notice of a material company event).

Directly affected

  • ELOX Eloxx Pharmaceuticals-4.6% 15d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.

  • XBI SPDR S&P Biotech ETF

    SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

  • PFE Pfizer+5.2% 30d

    Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

  • MRK Merck+3.5% 30d

    Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
ELOX+5.25%+5.25%baseafter closeafter closeafter closeafter close
XLV-0.28%+0.04%baseafter closeafter closeafter closeafter close
XBI+4.20%+3.78%baseafter closeafter closeafter closeafter close
LLY-2.25%-0.49%baseafter closeafter closeafter closeafter close
JNJ-1.35%-1.97%baseafter closeafter closeafter closeafter close
PFE+1.19%+1.90%baseafter closeafter closeafter closeafter close
MRK+0.65%-0.38%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-16 AccNo: 0001193125-26-462310 Size: 201 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

How far Eloxx Pharmaceuticals (ELOX) has moved since 16 Nov 2026

CompanyWhenMoveStatus
Eloxx Pharmaceuticals (ELOX)three days earlier+5.25%final price
Eloxx Pharmaceuticals (ELOX)five days earlier+5.25%final price
JNJthree days earlier-1.97%final price
JNJfive days earlier-1.35%final price
LLYthree days earlier-0.49%final price
LLYfive days earlier-2.25%final price
MRKthree days earlier-0.38%final price
MRKfive days earlier+0.65%final price
PFEthree days earlier+1.90%final price
PFEfive days earlier+1.19%final price
XBIthree days earlier+3.78%final price
XBIfive days earlier+4.20%final price
XLVthree days earlier+0.04%final price
XLVfive days earlier-0.28%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who is named in “8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer)”

Companies tied to this story

  • ELOX Eloxx Pharmaceuticals

    Eloxx Pharmaceuticals (ELOX) is linked, with no stored direction, high confidence in the 16 Nov 2026 story “8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> ELOX

How “8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer)” reaches Eloxx Pharmaceuticals (ELOX)

The 16 Nov 2026 story “8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer)” names Eloxx Pharmaceuticals (ELOX) because of this story.

Eloxx Pharmaceuticals (ELOX) is on the page because SEC 8-K filing -> direct issuer disclosure -> ELOX

Dates in the story, and the Eloxx Pharmaceuticals (ELOX) price range

ELOX traded between 11.53 and 13.79 across 15 sessions. The latest close on file is 12.74.

How solid “8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer)” looks

14 out of 100

“8-K - Eloxx Pharmaceuticals, Inc. (0001035354) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.